Skip to search formSkip to main contentSkip to account menu

BCR-ABL TKI-Resistant Mutation

Known as: BCR-ABL Tyrosine Kinase Inhibitor-Resistant Mutation 
A molecular genetic abnormality in the kinase domain of the BCR-ABL fusion gene that results in resistance to tyrosine kinase inhibitors.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Der EGFR-Tyrosinkinasehemmer (EGFR-TKI) Dacomitinib konnte bei Patienten mit fortgeschrittenem nichtkleinzelligem Lungenkarzinom… 
2014
2014
Mininmnya Lapangan Pekerjaan Di Indonesia Membuat Jumlah Pengangguran Semakin Meningkat. Meskipun Pemerintah Sudah Menciptakan…